Trump wants to split childhood shot up
President Donald Trump's latest executive order calls for splitting the measles, mumps and rubella, or MMR, vaccine into three separate...
HEALTH & FITNESS
Jazz Pharmaceuticals to buy Actio Biosciences for $820 million
Piotr Swat | Lightrocket | Getty ImagesCNBC Cures is proudly underwritten by Alexion, AstraZeneca Rare Disease, whose support enables our...
Eli Lilly wins U.K. approval, challenging Wegovy weight-loss pill
Eli Lilly has won its first approval to sell its weight-loss drug Foundayo outside the U.S., allowing it to compete...
Trump signs vaccine executive order calling for fewer childhood shots
Secretary of Health and Human Services Robert F. Kennedy Jr. looks on as President Donald Trump speaks before signing an...
New genetic tests are catching rare diseases before symptoms start
Westend61 | Westend61 | Getty ImagesCNBC Cures is proudly underwritten by Alexion, AstraZeneca Rare Disease, whose support enables our journalism...
We like Boeing’s Archer deal. Plus, what to expect from this health stock
Every weekday, the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a...
Hunter Biden says Joe Biden’s cancer has spread, is ‘very debilitating’
President Joe Biden stands with his son Hunter Biden after the president arrived at the Delaware Air National Guard Base...
Jim Cramer highlights 5 investing themes — and the stocks to buy for each
CNBC's Jim Cramer said Thursday earnings season has revealed investing themes he thinks will produce the market's best buying opportunities."I...
Sen. Mitch McConnell says he’s left rehab, will work from home
Senator Mitch McConnell (R-KY) is seen during a Senate Committee on Appropriations, Subcommittee on Department of Defense budget hearing at...
CAMP4 advances rare disease treatment for SYNGAP1 into human trials
CNBC Cures is proudly underwritten by Alexion, AstraZeneca Rare Disease, whose support enables our journalism to elevate stories that advance...
Eli Lilly, Novo Nordisk earnings show widening divide in GLP-1 market
The Eli Lilly and Novo Nordisk logos.Mike Blake | Tom Little | ReutersThe diverging paths of two GLP-1 drugmakers were...
AstraZeneca-Bristol Myers merger talks explained
Pharma investors reeled this week from reports that AstraZeneca held merger talks with U.S. rival Bristol Myers Squibb, a move...
This GLP-1 stock has bigger opportunities to boost its share price
Instead of betting on which single pharmaceutical company wins a drug race, West Pharmaceutical Services benefits as the industry grows...
GLP-1 drugs for employees cost $250M a year
Brian Moynihan, CEO of Bank of America, speaking to CNBC from Aspen, Co. on Aug. 5th, 2026.CNBCBank of America spends...
Eli Lilly (LLY) earnings Q2 2026
Eli Lilly on Wednesday reported second-quarter earnings and revenue that blew past estimates and hiked its full-year sales outlook, as demand...
Novo Nordisk stock falls as raised outlook fails to change the debate over obesity business
Novo Nordisk's quarterly beat and guidance increase did little to resolve Wall Street's biggest concern: whether the Ozempic maker has...
Novo Nordisk releases earnings and guidance
Novo Nordisk CEO Maziar Mike Doustdar waits for the start of the pharmaceutical company’s annual general meeting in Copenhagen, Denmark,...
Merck (MRK) earnings Q2 2026
The exterior view of the entrance to Merck headquarters in Rahway, New Jersey, on Feb. 5, 2024.Spencer Platt | Getty...
New Medicaid work rules could leave rare disease patients uninsured
CNBC Cures is proudly underwritten by Alexion, AstraZeneca Rare Disease, whose support enables our journalism to elevate stories that advance...
Novo Nordisk shares dive after heart medicine fails trial
Shares of Novo Nordisk fell as much as 10% on Friday after the drugmaker said a late-stage heart drug trial...
